Eva Lonn Selected Research

Vitamins

4/2009	Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
6/2007	Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.
4/2006	Homocysteine lowering with folic acid and B vitamins in vascular disease.
10/2004	Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva Lonn Research Topics

Disease

27	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
20	Stroke (Strokes) 12/2023 - 03/2002
17	Heart Failure 01/2024 - 01/2001
14	Myocardial Infarction 12/2023 - 09/2002
10	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 01/2001
9	Atherosclerosis 01/2021 - 09/2002
9	Vascular Diseases (Vascular Disease) 11/2008 - 01/2001
7	Neoplasms (Cancer) 01/2022 - 10/2004
7	Hypertension (High Blood Pressure) 01/2019 - 01/2002
7	Coronary Disease (Coronary Heart Disease) 09/2017 - 01/2005
5	Diabetes Mellitus 02/2023 - 12/2003
4	Obesity 01/2022 - 11/2010
4	Left Ventricular Dysfunction 01/2014 - 06/2004
4	Atrial Fibrillation 11/2012 - 01/2003
3	Venous Thromboembolism 01/2022 - 06/2007
3	Chronic Renal Insufficiency 01/2022 - 11/2016
3	Hemorrhage 01/2021 - 08/2005
3	Atherosclerotic Plaque (Atheroma) 09/2017 - 05/2014
3	Hyperkalemia 03/2014 - 01/2002
3	Insulin Resistance 05/2003 - 01/2002
2	Peripheral Arterial Disease 12/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2012
2	Abdominal Aortic Aneurysm 01/2021 - 11/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2009 - 09/2007
2	Coronary Vasospasm (Coronary Artery Vasospasm) 06/2009 - 04/2002
2	Thrombosis (Thrombus) 06/2009 - 09/2007
2	Pulmonary Embolism 04/2009 - 06/2007
2	Inflammation (Inflammations) 03/2008 - 03/2002
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2007 - 06/2007
2	Acute Coronary Syndrome 11/2005 - 10/2005
2	Abdominal Obesity 07/2003 - 01/2003
2	Renal Insufficiency (Renal Failure) 05/2003 - 01/2002
2	Acute Kidney Injury (Acute Renal Failure) 05/2003 - 01/2002
2	Vascular Remodeling 09/2002 - 03/2002
1	COVID-19 02/2024
1	Disease Progression 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2018
1	Body Weight (Weight, Body) 01/2018
1	Unstable Angina 01/2018
1	Erectile Dysfunction 01/2018
1	Cataract (Cataracts) 05/2016
1	Cognitive Dysfunction 03/2015
1	Alzheimer Disease (Alzheimer's Disease) 08/2014

Drug/Important Bio-Agent (IBA)

15	Ramipril (Altace)FDA LinkGeneric 01/2018 - 01/2002
11	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2009 - 01/2001
10	HomocysteineIBA 08/2014 - 01/2002
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 01/2005
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2005
7	Folic Acid (Vitamin M)FDA LinkGeneric 03/2013 - 10/2004
6	Rosuvastatin Calcium (Crestor)FDA Link 01/2022 - 05/2016
6	LipidsIBA 01/2022 - 08/2004
4	RivaroxabanIBA 12/2023 - 01/2018
4	LDL CholesterolIBA 01/2021 - 01/2005
4	CholesterolIBA 01/2019 - 05/2016
4	candesartanIBA 01/2019 - 05/2016
4	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2019 - 05/2016
4	Telmisartan (Micardis)FDA Link 01/2018 - 07/2009
4	darapladibIBA 09/2017 - 03/2010
4	Antihypertensive Agents (Antihypertensives)IBA 11/2012 - 08/2004
4	Vitamin E FDA LinkGeneric 07/2009 - 12/2003
4	VitaminsIBA 04/2009 - 10/2004
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2007 - 01/2001
3	sacubitril and valsartan sodium hydrate drug combinationIBA 02/2023 - 01/2019
3	omega-Chloroacetophenone (Mace)IBA 01/2019 - 05/2014
3	EnzymesIBA 05/2014 - 06/2009
3	CreatinineIBA 05/2012 - 01/2002
3	Biomarkers (Surrogate Marker)IBA 05/2012 - 07/2006
3	Vitamin B Complex (B Vitamins)IBA 10/2010 - 04/2006
3	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2009 - 03/2008
3	pro-brain natriuretic peptide (1-76)IBA 04/2009 - 07/2006
2	C-Reactive ProteinIBA 01/2022 - 07/2006
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2003
2	CalciumIBA 01/2020 - 09/2011
2	LDL Lipoproteins (beta Lipoproteins)IBA 05/2016 - 01/2005
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 05/2014 - 03/2010
2	Angiotensin Receptor AntagonistsIBA 12/2009 - 09/2002
2	Vitamin B 6IBA 04/2009 - 04/2006
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2009 - 04/2006
2	Atorvastatin (Lipitor)FDA Link 03/2008 - 01/2005
2	Amlodipine (Norvasc)FDA LinkGeneric 03/2008 - 01/2005
2	Lipoprotein(a)IBA 05/2003 - 01/2002
2	Arginine (L-Arginine)FDA Link 05/2003 - 01/2002
1	SymportersIBA 01/2022
1	SodiumIBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	PlacebosIBA 01/2018
1	Factor Xa InhibitorsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	trimethyloxamine (trimethylamine N-oxide)IBA 09/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 09/2015
1	Choline (Choline Chloride)IBA 09/2015

Therapy/Procedure

18	Therapeutics 02/2023 - 08/2002
5	Secondary Prevention 07/2016 - 03/2002
4	Drug Therapy (Chemotherapy) 01/2022 - 07/2006
2	Cardiac Rehabilitation 02/2024 - 01/2021
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 01/2003
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2024
1	Intramedullary Fracture Fixation 04/2021
1	Transjugular Intrahepatic Portasystemic Shunt 10/2018
1	Percutaneous Coronary Intervention 01/2018